A medication used to treat hypothyroidism has been voluntarily recalled due to quality concerns.
Westminster Pharmaceuticals, LLC has instructed wholesalers to stop distributing specific products labeled “Levothyroxine along with Liothyronine (Thyroid Tablets, USP),” according to an August 9 Discharge. Levothyroxine along with Liothyronine are synthetic hormones contained within the thyroid tablets.
The voluntary national recall alert says there have been no “adverse events” associated with the recalled products. that will says patients should continue taking the drugs.
More coming from USA Today:
Oatmeal, breakfast foods contain unsafe amounts of cancer-linked weed killer
is actually This particular drug the most promising development on Alzheimer’s in recent history?
FDA expands recall of heart drug for possible cancer-causing contamination
“Because these products may be used within the treatment of serious medical conditions, patients taking the recalled medicines should continue taking their medicine until they have a replacement product,” the Discharge says.
More than 4.5 percent of the U.S. population over the age of 12 suffers coming from an underactive thyroid or hypothyroidism, according to the National Library of Medicine’s MedlinePlus.
The Discharge instructs patients to speak with their physician before discontinuing use of the medicine.
The recall follows a June 22 warning letter coming from the Food & Drug Administration to a Chinese pharmaceutical company which manufactured active ingredients within the recalled drug. The letter cited quite a few failures, including ones relating to “established standards of quality along with purity.”
The recall alert says issues cited in that will warning letter “could represent the possibility of risk being introduced into the manufacturing process.”
A full list of recalled products is actually available coming from the FDA.
Patients with questions or information about an issue relating to the recalled products can contact Westminster at: 888-354-9939.